$5.16 Billion is the total value of Bellevue Group AG's 239 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 20.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ESPR | Buy | ESPERION THERAPEUTICS INC NEW | $158,844,000 | -41.1% | 5,037,890 | +11.3% | 3.08% | -28.0% |
| ARGX | Buy | ARGENX SEsponsored adr | $128,371,000 | -17.7% | 974,504 | +0.7% | 2.49% | +0.6% |
| ISRG | Buy | INTUITIVE SURGICAL INC | $109,130,000 | +4.7% | 220,371 | +25.0% | 2.12% | +28.1% |
| RDUS | Buy | RADIUS HEALTH INC | $90,784,000 | -35.1% | 6,983,385 | +0.6% | 1.76% | -20.6% |
| MDT | Buy | MEDTRONIC PLC | $85,249,000 | -11.4% | 945,316 | +11.4% | 1.65% | +8.3% |
| ANTM | Buy | ANTHEM INC | $83,007,000 | -15.5% | 365,603 | +12.4% | 1.61% | +3.4% |
| UNH | Buy | UNITEDHEALTH GROUP INC | $78,856,000 | -2.5% | 316,208 | +14.9% | 1.53% | +19.2% |
| EXEL | Buy | EXELIXIS INC | $68,457,000 | -1.2% | 3,975,400 | +1.1% | 1.33% | +20.9% |
| NKTR | Buy | NEKTAR THERAPEUTICS | $62,202,000 | -15.7% | 3,484,713 | +2.0% | 1.21% | +3.2% |
| CI | Buy | CIGNA CORP NEW | $61,887,000 | -5.2% | 349,289 | +9.4% | 1.20% | +15.9% |
| MYOK | Buy | MYOKARDIA INC | $61,493,000 | -35.4% | 1,311,713 | +0.4% | 1.19% | -20.9% |
| ITCI | Buy | INTRA CELLULAR THERAPIES INC | $57,358,000 | -29.3% | 3,731,819 | +57.7% | 1.11% | -13.6% |
| ARVN | Buy | ARVINAS INC | $51,153,000 | +0.2% | 1,269,303 | +2.2% | 0.99% | +22.6% |
| CNC | Buy | CENTENE CORP DEL | $48,138,000 | +3.4% | 810,270 | +9.4% | 0.93% | +26.6% |
| BAX | Buy | BAXTER INTL INC | $48,058,000 | +6.5% | 591,921 | +9.7% | 0.93% | +30.3% |
| AKCA | Buy | AKCEA THERAPEUTICS INC | $45,821,000 | -14.5% | 3,204,244 | +1.3% | 0.89% | +4.7% |
| EW | Buy | EDWARDS LIFESCIENCES CORP | $44,130,000 | -6.7% | 233,965 | +15.4% | 0.86% | +14.1% |
| CRL | Buy | CHARLES RIV LABS INTL INC | $41,854,000 | -3.2% | 331,623 | +17.1% | 0.81% | +18.4% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $40,728,000 | -56.9% | 1,418,104 | +8.3% | 0.79% | -47.3% |
| MTEM | Buy | MOLECULAR TEMPLATES INC | $38,682,000 | +113.5% | 2,910,640 | +124.6% | 0.75% | +161.3% |
| MGNX | Buy | MACROGENICS INC | $35,614,000 | -44.3% | 6,119,150 | +4.2% | 0.69% | -31.8% |
| FATE | Buy | FATE THERAPEUTICS INC | $34,719,000 | +2043.1% | 1,563,200 | +1787.9% | 0.67% | +2488.5% |
| CRSP | Buy | CRISPR THERAPEUTICS AGnamen akt | $33,948,000 | -23.7% | 800,462 | +9.6% | 0.66% | -6.7% |
| BDTX | New | BLACK DIAMOND THERAPEUTICS I | $33,184,000 | – | 1,330,000 | +100.0% | 0.64% | – |
| SRRK | Buy | SCHOLAR ROCK HOLDING CORP | $32,880,000 | -5.3% | 2,715,106 | +3.1% | 0.64% | +16.0% |
| HRC | Buy | HILL ROM HLDGS INC | $29,725,000 | +10.3% | 295,479 | +24.5% | 0.58% | +34.9% |
| SYK | Buy | STRYKER CORP | $28,755,000 | -15.1% | 172,713 | +7.1% | 0.56% | +3.9% |
| CDNA | Buy | CAREDX INC | $27,878,000 | +9.8% | 1,277,051 | +8.5% | 0.54% | +34.6% |
| DXCM | Buy | DEXCOM INC | $27,285,000 | +58.9% | 101,328 | +29.1% | 0.53% | +94.5% |
| AMGN | Buy | AMGEN INC | $26,674,000 | +174.2% | 131,573 | +226.1% | 0.52% | +235.7% |
| INSM | Buy | INSMED INC | $25,864,000 | -31.6% | 1,613,470 | +1.9% | 0.50% | -16.3% |
| VYGR | Buy | VOYAGER THERAPEUTICS INC | $24,926,000 | -33.9% | 2,724,083 | +0.7% | 0.48% | -19.2% |
| EVH | Buy | EVOLENT HEALTH INCcl a | $24,872,000 | -22.6% | 4,580,458 | +29.1% | 0.48% | -5.3% |
| HCA | Buy | HCA HEALTHCARE INC | $24,526,000 | -34.3% | 272,966 | +8.1% | 0.48% | -19.6% |
| WVE | Buy | WAVE LIFE SCIENCES LTD | $24,389,000 | +26.6% | 2,602,858 | +8.3% | 0.47% | +55.1% |
| TFX | Buy | TELEFLEX INCORPORATED | $22,941,000 | -18.4% | 78,333 | +4.8% | 0.44% | -0.2% |
| PACB | Buy | PACIFIC BIOSIENCES CALIF IN | $22,579,000 | -23.4% | 7,378,791 | +28.7% | 0.44% | -6.2% |
| GWPH | Buy | GW PHARMACEUTICALS PLCads | $21,977,000 | +1776.8% | 250,966 | +2140.8% | 0.43% | +2142.1% |
| BIO | Buy | BIO RAD LABS INCcl a | $21,865,000 | +26.3% | 62,373 | +33.3% | 0.42% | +54.7% |
| HOLX | Buy | HOLOGIC INC | $19,929,000 | +45.8% | 567,779 | +116.9% | 0.39% | +77.9% |
| PODD | Buy | INSULET CORP | $16,957,000 | -2.3% | 102,350 | +0.9% | 0.33% | +19.6% |
| MASI | Buy | MASIMO CORP | $16,338,000 | +30.8% | 92,245 | +16.7% | 0.32% | +60.1% |
| ABMD | Buy | ABIOMED INC | $15,688,000 | +4.7% | 108,072 | +23.0% | 0.30% | +27.7% |
| KZR | Buy | KEZAR LIFE SCIENCES INC | $15,342,000 | +146.7% | 3,518,889 | +126.9% | 0.30% | +201.0% |
| HCM | Buy | HUTCHISON CHINA MEDITECH LTDsponsored adr | $15,208,000 | -25.8% | 851,994 | +4.2% | 0.30% | -9.2% |
| HMSY | Buy | HMS HLDGS CORP | $14,535,000 | -5.1% | 575,177 | +11.2% | 0.28% | +16.0% |
| GMED | Buy | GLOBUS MED INCcl a | $14,378,000 | -27.7% | 338,067 | +0.1% | 0.28% | -11.4% |
| PEN | Buy | PENUMBRA INC | $13,251,000 | +17.2% | 82,139 | +19.3% | 0.26% | +43.6% |
| GKOS | Buy | GLAUKOS CORP | $12,734,000 | -41.9% | 412,623 | +2.6% | 0.25% | -28.8% |
| CVS | Buy | CVS HEALTH CORP | $12,636,000 | -17.9% | 212,981 | +2.8% | 0.24% | +0.4% |
| RMD | Buy | RESMED INC | $11,563,000 | -1.6% | 78,505 | +3.6% | 0.22% | +20.4% |
| AMED | Buy | AMEDISYS INC | $11,222,000 | +26.0% | 61,143 | +14.6% | 0.22% | +54.6% |
| TRHC | Buy | TABULA RASA HEALTHCARE INC | $10,919,000 | +11.2% | 208,809 | +3.6% | 0.21% | +35.9% |
| SWAV | Buy | SHOCKWAVE MED INC | $10,772,000 | +16.4% | 324,661 | +54.0% | 0.21% | +42.2% |
| GILD | Buy | GILEAD SCIENCES INC | $10,803,000 | +1857.1% | 144,500 | +1600.0% | 0.21% | +2222.2% |
| CHNG | Buy | CHANGE HEALTHCARE INC | $10,765,000 | -24.0% | 1,077,575 | +24.7% | 0.21% | -6.7% |
| QTRX | Buy | QUANTERIX CORP | $8,187,000 | -20.4% | 445,673 | +2.4% | 0.16% | -2.5% |
| ZLAB | Buy | ZAI LAB LTDadr | $7,928,000 | +57.8% | 154,000 | +27.5% | 0.15% | +92.5% |
| LVGO | Buy | LIVONGO HEALTH INC | $7,738,000 | +69.1% | 271,232 | +48.6% | 0.15% | +105.5% |
| PHR | Buy | PHREESIA INC | $7,592,000 | +5.1% | 360,998 | +33.2% | 0.15% | +28.9% |
| VCRA | Buy | VOCERA COMMUNICATONS INC | $7,449,000 | +18.0% | 350,724 | +15.3% | 0.14% | +44.0% |
| BGNE | Buy | BEIGENE LTDsponsored adr | $7,202,000 | -7.3% | 58,500 | +24.9% | 0.14% | +13.8% |
| CDTX | Buy | CIDARA THERAPEUTICS INC | $7,000,000 | -20.6% | 2,822,495 | +23.0% | 0.14% | -2.9% |
| HCAT | Buy | HEALTH CATALYST INC | $6,616,000 | -15.1% | 253,000 | +12.7% | 0.13% | +3.2% |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $6,133,000 | -42.1% | 662,315 | +3.8% | 0.12% | -29.2% |
| SILK | Buy | SILK RD MED INC | $6,125,000 | -17.5% | 194,583 | +5.8% | 0.12% | +0.8% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $6,092,000 | +7.2% | 72,100 | +7.3% | 0.12% | +31.1% |
| SGEN | Buy | SEATTLE GENETICS INC | $4,777,000 | +11.8% | 41,400 | +10.7% | 0.09% | +36.8% |
| ONEM | New | 1LIFE HEALTHCARE INC | $4,538,000 | – | 250,000 | +100.0% | 0.09% | – |
| AXNX | New | AXONICS MODULATION TECHNOLOG | $4,557,000 | – | 179,333 | +100.0% | 0.09% | – |
| PFE | Buy | PFIZER INC | $2,938,000 | +25.0% | 90,000 | +50.0% | 0.06% | +54.1% |
| PTCT | Buy | PTC THERAPEUTICS INC | $2,909,000 | +8.0% | 65,200 | +16.2% | 0.06% | +30.2% |
| PANW | New | PALO ALTO NETWORKS INC | $2,787,000 | – | 17,000 | +100.0% | 0.05% | – |
| UBER | New | UBER TECHNOLOGIES INC | $2,792,000 | – | 100,000 | +100.0% | 0.05% | – |
| TEVA | Buy | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $2,721,000 | +4.4% | 303,000 | +13.9% | 0.05% | +29.3% |
| BIIB | Buy | BIOGEN INC | $2,689,000 | +1716.9% | 8,500 | +1600.0% | 0.05% | +2500.0% |
| SYNH | Buy | SYNEOS HEALTH INCcl a | $2,440,000 | -10.0% | 61,900 | +35.7% | 0.05% | +9.3% |
| CTLT | Buy | CATALENT INC | $2,447,000 | +26.7% | 47,100 | +37.3% | 0.05% | +51.6% |
| LH | Buy | LABORATORY CORP AMER HLDGS | $2,257,000 | +141.4% | 17,861 | +223.2% | 0.04% | +193.3% |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $1,956,000 | -2.2% | 20,000 | +29.0% | 0.04% | +18.8% |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $1,775,000 | +3.7% | 42,000 | +5.0% | 0.03% | +25.9% |
| QURE | Buy | UNIQURE NV | $1,495,000 | -27.8% | 31,500 | +9.0% | 0.03% | -12.1% |
| ASND | New | ASCENDIS PHARMA A Ssponsored adr | $1,340,000 | – | 11,900 | +100.0% | 0.03% | – |
| RGNX | Buy | REGENXBIO INC | $1,195,000 | +39.6% | 36,900 | +76.6% | 0.02% | +64.3% |
| PRGO | New | PERRIGO CO PLC | $981,000 | – | 20,400 | +100.0% | 0.02% | – |
| RARE | New | ULTRAGENYX PHARMACEUTICAL IN | $955,000 | – | 21,500 | +100.0% | 0.02% | – |
| BLUE | Buy | BLUEBIRD BIO INC | $910,000 | -43.3% | 19,800 | +8.2% | 0.02% | -28.0% |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $844,000 | -31.7% | 24,800 | +9.3% | 0.02% | -20.0% |
| APLS | New | APELLIS PHARMACUETICALS INC | $801,000 | – | 29,900 | +100.0% | 0.02% | – |
| YI | New | 111 INCads | $763,000 | – | 115,429 | +100.0% | 0.02% | – |
| ZYME | New | ZYMEWORKS INC | $653,000 | – | 18,400 | +100.0% | 0.01% | – |
| CLLS | New | CELLECTIS S Asponsored ads | $693,000 | – | 75,300 | +100.0% | 0.01% | – |
| CSGP | New | COSTAR GROUP INC | $411,000 | – | 700 | +100.0% | 0.01% | – |
| LABU | New | DIREXION SHS ETF TRsp biotech bl new | $338,000 | – | 15,000 | +100.0% | 0.01% | – |
| MTCH | New | MATCH GROUP INC | $350,000 | – | 5,300 | +100.0% | 0.01% | – |
| IQV | New | IQVIA HLDGS INC | $205,000 | – | 1,900 | +100.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- BB Biotech AG #1
- Bellevue Asset Management AG #2
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IONIS PHARMACEUTICALS INC | 31 | Q3 2023 | 9.3% |
| Vertex Pharmaceuticals Incorporated | 31 | Q3 2023 | 5.9% |
| NEUROCRINE BIOSCIENCES INC | 31 | Q3 2023 | 5.7% |
| Incyte Corporation | 31 | Q3 2023 | 5.4% |
| INTUITIVE SURGICAL INC | 31 | Q3 2023 | 4.7% |
| ABBOTT LABS | 31 | Q3 2023 | 4.6% |
| ELEVANCE HEALTH INC | 31 | Q3 2023 | 4.3% |
| UnitedHealth Group Incorporated | 31 | Q3 2023 | 3.6% |
| ALNYLAM PHARMACEUTICALS INC | 31 | Q3 2023 | 3.7% |
| Boston Scientific Corporation | 31 | Q3 2023 | 2.5% |
View Bellevue Group AG's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-02-14 |
| SC 13G | 2023-02-14 |
| 13F-HR | 2022-11-14 |
View Bellevue Group AG's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.